Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Novo Nordisk Q3 Adj. Operating Profit Increases, Obesity Sales Up 22%; Raises 2026 Outlook

(RTTNews) - Novo Nordisk A/S (NVO, NOVOB.CO, NOV.DE) reported third quarter net profit of 16.74 billion Danish kroner, a decline of 16% year-over-year. Earnings per share/ ADR was 3.79 kroner, down 16%. Adjusted net profit was 25.60 billion kroner, down 12% from last year. Adjust

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

Read the original at nasdaq.com →

More in Finance & Markets

More from Wednesday 4 November →